Table of Contents Table of Contents
Previous Page  259 / 290 Next Page
Information
Show Menu
Previous Page 259 / 290 Next Page
Page Background

Results:

N = 51 patients; 82.4% women; mean age 88 years old; 8.6

medicines per patient; 6 patients: more than 1 medicine withdrawal;

34 immediate replacement; 10: dose reduction; 9: posology frequency

reduction. Removal of 44 benzodiazepines, 5 hypnotics, 2 tricyclic

antidepressant. 100% started trazodone as an alternative treatment.

Prescription follow up monitoring: 42 patients maintained prescrip-

tion switch recommendation.

Conclusion:

In patients presenting psychotropic adverse side effects,

trazodone could be an adequate therapeutic alternative on psycho-

tropic withdrawal. The stay in Orthogeriatric Units due to hip fracture

could be a suitable moment to assess the convenience of withdrawal,

reduction or substitution of some chronic medications, specially

psychotropics.

P-848

Prevalence and risk factors of depression in elderly inpatients

H. Salma

1

, C. Fadwa

1

, M. Sameh

2

, A. Lobna

1

, G. Radhwan

2

, B. Zouhair

2

,

A. Othmen

1

.

1

Psychiatric Department

B

of CHU Hédi Chaker,

2

Internal

Medicine department of CHU HédiChaker, Sfax, Tunisia

Objectives:

Depression in the elderly is a widespread problem that is

associated with several psychosocial and medical factors. The aims of

this study were to estimate the prevalence of depression and to

identify its associated factors in elderly hospitalized patients.

Methods:

A descriptive and analytic study including 60 inpatients

aged over 65, who were hospitalized in the Internal Medicine depart-

ment of CHU Hédi Chaker, Sfax, during the period from September

2015 until January 2016. Data collectionwas conducted via a question-

naire exploring sociodemographic and medical data. Depression was

assessed by the 15-item Geriatric Depression Scale (GDS-15).

Results:

The average age of patients was 73, 48 ± 6,57 years. The

socioeconomic level was mostly middling (83,3%). In our study, 18.4%

of patients were living alone. Social and family problems were

reported by 18.3% of patients. According to GDS-15, 21.7% of cases

suffered from severe depression (score >12). A significant association

was found between Female sex (p = 0,004), social or family problem

(p = 0,000), social isolation (p = 0,001) and being dependent for

activities of daily living(p = 0,005) with severe depression.

Conclusion:

Depression is very common in elderly hospitalized

patients. A systematic screening for this trouble in this population

seemed to be necessary.

P-849

Deciding on the treatment for challenging behaviors in patients

with dementia

S. Janus

1

, J. van Manen

1

, J. van Til

1

, S. Zuidema

2

, M.I. Jzerman

1

.

1

University of Twente,

2

University of Groningen, Netherlands

Introduction:

There is concern about prescribing antipsychotics for

patients with neuropsychiatric symptoms. For patients with dementia,

physicians have to make the treatment decision together with proxies.

It is unknown whether physicians, nurses and proxies would make

the same treatment choice for the patient. Therefore, this study

compares the ranking of attributes of antipsychotic treatment

according to its importance for the treatment decisions between

these groups.

Method:

16 and 10 attributes were selected for physicians/nurses and

proxies respectively. A scenario depicting a patient with dementia

demonstrating neuropsychiatric symptoms was shown and respon-

dents had to choose an appropriate treatment (antipsychotics/

non-pharmaceutical treatment). The attributes were rated by the

respondents according to their choice using a Best-Worst Scaling case

1 design.

Results:

41 physicians, 81 nurses and 59 proxies filled in the

questionnaire. The antipsychotic treatment option was chosen by

71% of the physicians, 71% of the nurses and 52% of the proxies. The

respondents who chose antipsychotics rated

leading to a result the

fastest

and

most effective

as most important. Only proxies rated

the factor

having a low negative impact on the patient

as important.

Of the respondents choosing the non-pharmaceutical treatment,

nurses and elderly care physicians ranked

appropriateness

and

of

little burden to the patient

as important. Proxies ranked

effective-

ness

and

least negative impact on the patient

as important.

Conclusion:

Effectiveness and negative impact of the two treatments

were ranked differently. Proxies should be informed about side effects

of psychotropics, and consented in a shared-decision making process

about the preferred treatment option.

P-850

The outcomes of a care pathway for depression screening among

respiratory insufficiency patients in pulmonary outpatient clinic

H. Kerminen

1,2

, E. Jämsen

1

3

, P. Jäntti

2

, A.K. Mattila

4

, S. Leivo-Korpela

5

,

J. Valvanne

1,2,6

.

1

Department of Internal Medicine, Tampere University

Hospital,

2

University of Tampere, School of Medicine and the Gerontology

Research Center,

3

Hatanpää Hospital, Service Line of General Practice and

Geriatrics,

4

Department of Adult Psychiatry, Tampere University Hospital,

General Hospital Psychiatry Unit,

5

Department of Respiratory Diseases,

Tampere University Hospital,

6

Purchaser for the Promotion of Senior

Citizens Welfare, City of Tampere, Tampere, Finland

Introduction:

Major depression is prevalent, but often undiagnosed,

among patients with chronic respiratory insufficiency. We developed

a care pathway for identifying depression in patients visiting a

tertiary care pulmonary outpatient clinic. Patients with Depression

Scale (DEPS) scores suggesting depression were offered a referral to

psychiatry service.

Methods:

149 patients (mean age 71 years, 60% males) visited the

clinic during a five-month period. The most prevalent diagnoses were

COPD (50%), sleep apnoea (34%), and obesity-hypoventilation (26%).

47% were using long-term oxygen therapy and 60% non-invasive

ventilation. We evaluated the outcomes of the care pathway by

retrospectively reviewing patient records.

Results:

DEPS was administered to 98 patients (66%), of whom 24%

scored

12 exceeding the cut-off for referral. Twelve patients refused

referral. Of the eight patients referred, five patients were finally

evaluated by a psychiatric nurse, and they all were deemed depressive.

Age, gender, body mass index and pulmonary disease diagnoses were

comparable in groups scoring <12 and

12 in DEPS. 12/25 of patients

with smoking history >40 pack-years had positive screen, compared

to 5/29 with 20

40 pack-years and 7/44 with lesser or no smoking

history (p = 0.007). History of depression (7/16 vs.17/82, p = 0.060) and

poorer lung function (FEV1% 32.5 vs. 51, p = 0.098, n = 57) seemed to be

associated with higher DEPS scores.

Key conclusions:

Depression screening was positive in one-fourth of

screened patients. Patients

compliance for further mood evaluation

in psychiatry outpatient clinic was poor. Screening, evaluation and

beginning of treatment should be done in parallel with the treatment

in pulmonary clinic.

P-851

Clozapine induced cardiomiopathy in Parkinson

s disease

U. Lertxundi, R. Hernández, F. Cibrian, M. García, C. Aguirre.

Pharmacy

and Internal Medicine, Araba

s Mental Health Network, Basque

Pharmacovigilance Unit

Introduction:

Cardiomyopathy is considered to be a very rare, poten-

tially fatal adverse reaction (ADR) associated with clozapine, although

the real incidence might be greatly underestimated. So far, this ADR

has only been described in relatively young schizophrenic patients,

with higher incidence reported rates in Oceania. But clozapine is also

used to treat psychotic symptoms in elderly patients, like patients with

Parkinson

s Disease (PD).

Method:

We searched for cardiomyopathy cases associated with

clozapine in PD existing in the European pahrmacovigilance database

(Eudravigilance), which includes spontaneously reported ADR from

the European Economic Area and in the case of clozapine, for which

the marketing authorization holder is in Switzerland (Novartis),

notifications from anywhere in the world. The Pharmacovigilance

Poster presentations / European Geriatric Medicine 7S1 (2016) S29

S259

S253